Harvard Apparatus Regenerative Technology, Inc. (HRGN) stock
HRGNOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$2.21−0.02 (-0.72%)
Close on Oct 19, 2026Market cap $38.92MP/E –Yield –
Harvard Apparatus Regenerative Technology operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Harvard Apparatus Regenerative Technology's operating cash flow for the twelve months ending Jun 30, 2026 was -$3.64M. For fiscal 2025 it was -$3.83M. The highest annual figure on record is -$2.63M in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$3.83M | – |
| FY2024 | Dec 31, 2024 | -$4.85M | – |
| FY2023 | Dec 31, 2023 | -$6.94M | – |
| FY2022 | Dec 31, 2022 | -$5.11M | – |
| FY2021 | Dec 31, 2021 | -$2.63M | – |
| FY2020 | Dec 31, 2020 | -$4.04M | – |
| FY2019 | Dec 31, 2019 | -$6.06M | – |
| FY2018 | Dec 31, 2018 | -$7.64M | – |
| FY2017 | Dec 31, 2017 | -$11.01M | – |
| FY2016 | Dec 31, 2016 | -$9.06M | – |
| FY2015 | Dec 31, 2015 | -$7.19M | – |
| FY2014 | Dec 31, 2014 | -$7.99M | – |
| FY2013 | Dec 31, 2013 | -$7.69M | – |
| FY2012 | Dec 31, 2012 | -$5.90M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$569.00K | – |
| Q1 FY2026 | Mar 31, 2026 | -$937.00K | – |
| Q4 FY2025 | Dec 31, 2025 | -$664.00K | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.47M | – |
| Q2 FY2025 | Jun 30, 2025 | -$941.00K | – |
| Q1 FY2025 | Mar 31, 2025 | -$758.00K | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.13M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.47M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.29M | – |
| Q1 FY2024 | Mar 31, 2024 | -$960.00K | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.22M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.16M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.55M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.01M | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.73M | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.72M | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.14M | – |
| Q1 FY2022 | Mar 31, 2022 | -$519.00K | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.00M | – |
| Q3 FY2021 | Sep 30, 2021 | -$454.00K | – |
| Q2 FY2021 | Jun 30, 2021 | -$613.00K | – |
| Q1 FY2021 | Mar 31, 2021 | -$560.00K | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.02M | – |
| Q3 FY2020 | Sep 30, 2020 | -$855.00K | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.07M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.09M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.44M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.36M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.04M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.22M | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.18M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.23M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.17M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.06M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.65M | – |
| Q3 FY2017 | Sep 30, 2017 | -$3.17M | – |
| Q2 FY2017 | Jun 30, 2017 | -$3.14M | – |
| Q1 FY2017 | Mar 31, 2017 | -$3.06M | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.99M | – |
| Q3 FY2016 | Sep 30, 2016 | -$2.09M | – |
See a number that looks wrong?